SANA BIOTECHNOLOGY IN

Sana Biotechnology Announces Multiple Preclinical Data Presentations to Showcase Its Hypoimmune Platform, Including in Type 1 Diabetes, at the Upcoming ISSCR 2022 Annual Meeting

13 يونيو 2022 15:05:00 بحسب Nasdaq GlobeNewswire

Sana Biotechnology to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference

07 يونيو 2022 15:05:00 بحسب Nasdaq GlobeNewswire

Sana Biotechnology Announces Plan to Relocate Manufacturing to Bothell, Washington Along with Key Executive Hires in Manufacturing and Regulatory

01 يونيو 2022 15:05:00 بحسب Nasdaq GlobeNewswire

Sana Biotechnology Congratulates Senior Vice President and Head of T Cell Therapeutics, Terry Fry, M.D., on Additional Role at the University of Colorado’s Gates Institute

12 مايو 2022 16:40:02 بحسب Nasdaq GlobeNewswire

Sana Biotechnology Reports First Quarter 2022 Financial Results and Business Updates

10 مايو 2022 15:05:01 بحسب Nasdaq GlobeNewswire

Sana Biotechnology to Present at the BofA Securities 2022 Healthcare Conference

04 مايو 2022 15:05:01 بحسب Nasdaq GlobeNewswire

Sana Biotechnology to Present Data from Multiple Preclinical Studies at the American Society of Gene and Cell Therapy 25th Annual Meeting

02 مايو 2022 15:35:00 بحسب Nasdaq GlobeNewswire

Sana Biotechnology Reports Fourth Quarter and Full Year 2021 Financial Results and Business Updates

16 مارس 2022 07:30:00 بحسب Nasdaq GlobeNewswire

Sana Biotechnology to Present at the 32nd Annual Oppenheimer Healthcare Conference

09 مارس 2022 15:05:00 بحسب Nasdaq GlobeNewswire

Sana Biotechnology to Present Preclinical Data on its Engineered Hypoimmune Allogeneic CAR T Cells at the 2022 American Association for Cancer Research Annual Meeting

08 مارس 2022 15:35:00 بحسب Nasdaq GlobeNewswire

Sana Biotechnology Obtains Exclusive License from National Institutes of Health for CD22 CAR Construct

11 يناير 2022 05:00:00 بحسب Nasdaq GlobeNewswire

Sana Biotechnology, IASO Biotherapeutics, and Innovent Biologics Announce Non-Exclusive License Agreement for Clinically Validated BCMA CAR Construct

10 يناير 2022 15:30:00 بحسب Nasdaq GlobeNewswire

Sana Biotechnology to Present at the 40th Annual J.P. Morgan Healthcare Conference

04 يناير 2022 15:05:00 بحسب Nasdaq GlobeNewswire

Sana Biotechnology Presentations at 2021 ASH Annual Meeting Highlight Progress with Platforms and CAR T Cell Programs

12 ديسمبر 2021 08:05:00 بحسب Nasdaq GlobeNewswire

Sana Biotechnology Reports Third Quarter 2021 Financial Results and Business Updates

08 نوفمبر 2021 15:05:02 بحسب Nasdaq GlobeNewswire

Sana Biotechnology to Present Pre-Clinical Data at 2021 American Society of Hematology Annual Meeting

04 نوفمبر 2021 08:07:03 بحسب Nasdaq GlobeNewswire

Sana Biotechnology Obtains a Non-Exclusive License to CRISPR Cas12b Gene Editing Technology from Beam Therapeutics to Enable Engineered Cell Programs

19 أكتوبر 2021 08:00:01 بحسب Nasdaq GlobeNewswire

Sana Biotechnology to Present at the Morgan Stanley 19th Annual Global Healthcare Conference

07 سبتمبر 2021 15:05:00 بحسب Nasdaq GlobeNewswire

Sana Biotechnology Reports Second Quarter 2021 Financial Results and Business Updates

04 أغسطس 2021 15:05:04 بحسب Nasdaq GlobeNewswire

Sana Biotechnology Enters Long-Term Lease to Establish Manufacturing Facility to Enable Its Gene and Cell Therapy Product Candidates

14 يوليو 2021 15:10:00 بحسب Nasdaq GlobeNewswire